3 completed, 1 terminated, 1 unknown. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 3, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Bone Tumor: new trials by email Literature Review of Bone Tumor trials Research Report on Bone Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Dose Finding Study to Treat Bone Tumor(s) 153-Sm-DOTMP (Samarium-153-DOTMP) - Bone Cancer, Bone Tumor | Phase 1 | Terminated | QSAM Therapeutics, Inc. | 5 | 2022-04-05 | 2026-07-23 |
| Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW032 and Xgeva® in Healthy Adults MW032, Xgeva® - Bone Tumor | Phase 1 | Completed | Mabwell (Shanghai) Bioscience Co., Ltd. | 120 | 2019-06-25 | 2021-03-15 |
| Phase Ⅰ Clinical Study Protocol of GB223 Monoclonal Antibody Injection GB223,7mg/kg, GB223,21mg/kg, GB223,63mg/kg - Bone Tumor | Phase 1 | Unknown | Genor Biopharma Co., Ltd. | 44 | 2018-11-16 | 2019-11-26 |
| Trabectedin Plus Olaparib in Metastatic or Advanced Sarcomas (TOMAS) trabectedin, olaparib - Soft Tissue Sarcoma, Bone Tumor | Phase 1 | Completed | Italian Sarcoma Group | 50 | 2014-07-20 | 2021-04-14 |
| Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia. Microwave ablation with Acculis Accu2i pMTA Applicator - Lung Tumor, Bone Tumor | Phase 1 / Phase 2 | Completed | Centre Hospitalier Universitaire de Besancon | 30 | 2012-09-01 | 2016-08-11 |
Bone Neoplasms (5) · Carcinoma, Renal Cell (1) · Lung Neoplasms (1) · Sarcoma (1)
Bone Diseases (5) · Musculoskeletal Diseases (5) · Neoplasms (5) · Neoplasms by Site (5) · Neoplasms by Histologic Type (2) · Adenocarcinoma (1) · Carcinoma (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Kidney Neoplasms (1) · Lung Diseases (1) · Male Urogenital Diseases (1) · Neoplasms, Connective and Soft Tissue (1) · Neoplasms, Glandular and Epithelial (1)
Denosumab (1) · Trabectedin (1) · olaparib (1)
Centre Hospitalier Universitaire de Besancon (1) · Genor Biopharma Co., Ltd. (1) · Italian Sarcoma Group (1) · Mabwell (Shanghai) Bioscience Co., Ltd. (1) · QSAM Therapeutics, Inc. (1)
China (2) · France (1) · Italy (1) · United States (1)
Barry Sugarman (1) · Giovanni Grignani, MD (1) · Haiyan Liu, Bachelor (1)